Inflammatory Breast Cancer Stage IV
4 clinical trials · Condition
◉ Watch Inflammatory Breast Cancer Stage IV
| Record | Firm | Date |
|---|---|---|
| Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC (NCT03184558) | BerGenBio ASA | 2017-07-26 |
| Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (NCT01583426) | GBG Forschungs GmbH | 2012-07-01 |
| Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (NCT01426880) | GBG Forschungs GmbH | 2011-08-01 |
Track Inflammatory Breast Cancer Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.